On Saturday, March 2, MSC Cruises, the leading cruise line in Europe officially welcomed the latest addition to the Company’s modern fleet - MSC Bellissima. The Company’s new flagship was named in a glamourous and traditional maritime Naming Ceremony in the port of Southampton. A host of stars, VIPs, key travel partners and international media attended the event as well as top management from MSC Cruises and its parent company MSC Group. Gianluigi Aponte, MSC Group’s founder and executive chairman as well as the ship owner, attended together with the Aponte and Aponte-Vago families. MSC Cruises’ Godmother Sophia Loren officially named her 14th ship, which is fitting since the glamourous Hollywood legend is renowned for her style and elegance.
To view the multimedia release go to:
https://www.multivu.com/players/English/8354652-msc-cruises-bellissima-ship-christening/
The sunny side of EGGS!
Master chef and National Geographic Explorer Barton Seaver gives kid-friendly tips
on cooking eggs from his new book, which is packed with scrumptious seasonal
recipes, fun food facts and challenges, tips on sustainability, and more. Find out more at http://www.NGKidsCookbook.com. Find other Cookbook segments at http://www.YouTube.com/natgeofan Food/Health/education
Messe Frankfurt is continuing to expand its presence in Russia with the acquisition of a 50 percent stake in Comtrans and Autotrans by its Russian subsidiary Messe Frankfurt RUS. The remaining 50 percent will be assumed by ITE Expo OOO, the Russian subsidiary of the ITE Group. The new Joint Venture organizing company is ITEMF Expo AO.
Comtrans – which has had the status of International Commercial Vehicle Auto Show since 2011 – will present the latest models of modern motor trucks, buses, trailers and their parts from September 8-12 at Crocus Expo in Moscow.
To view the multimedia news release, go to http://www.multivu.com/players/English/7577851-messe-frankfurt-comtrans-2015/
Following FDA approval of the AspireSR® generator for the VNS Therapy® system in June 2015, more than a thousand patients with drug-resistant epilepsy across the United States have received this new treatment option. Many of these patients are experiencing benefits which have positively impacted their lives – and are sharing their stories during Epilepsy Awareness Month with the hope of encouraging others to seek new treatments for drug-resistant epilepsy. Numerous hospitals nationwide have begun providing the AspireSR device to patients with drug-resistant epilepsy – a condition that affects as many as one-third of people with epilepsy, causing them to have seizures in spite of treatment with antiepileptic medications.
The VNS Therapy system is a minimally invasive option in which a medical device is placed under the skin in the upper chest area during an outpatient procedure. The device sends mild electrical pulses through the vagus nerve to areas of the brain known to be associated with seizures. The new AspireSR generator takes the VNS Therapy technology a step further – detecting relative heart-rate increases that are often associated with seizures in people with epilepsy and providing responsive stimulation in an attempt to stop and shorten seizures and improve recovery.
To view the multimedia release go to:
http://www.multivu.com/players/English/7651751-livanova-aspiresr-treatment/
